News Center

位置：

Honors Announcement

Group News

Media Reports

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the Vietnam International Pharmaceutical Exhibition

Category:

Group News

发布时间：2025-05-08

【概要描述】 Today, the 32nd Vietnam International Pharmaceutical Exhibition (VIETNAM MEDI-PHARM 2025) opened in Hanoi. Leveraging the exhibition as a strategic platform, Shijiazhuang Sihua Pharmaceutical Group is showcasing its corporate image, expanding its network of partnerships, and exploring business opportunities, thereby actively pursuing market expansion in Southeast Asia.

Shijiazhuang Sihua Pharmaceutical Group Makes Its Debut at the Vietnam International Pharmaceutical Exhibition

Today, the 32nd Vietnam International Pharmaceutical Exhibition (VIETNAM MEDI-PHARM 2025) opened in Hanoi. Leveraging the exhibition as a strategic platform, Shijiazhuang Sihua Pharmaceutical Group is showcasing its brand image, expanding its network of partnerships, and exploring business opportunities, with a proactive focus on developing the Southeast Asian market.

The Vietnam International Pharmaceutical Exhibition is one of the most influential pharmaceutical industry events in Southeast Asia. This year’s edition is themed “Innovative Technologies, Healthy Future,” bringing together 450 exhibiting companies from more than 30 countries, including China, the United States, Germany, and India, to showcase the latest advancements in pharmaceuticals, functional foods, medical devices, and cutting-edge technologies.

This time, the Group’s key product offerings include the moxifloxacin series, azithromycin series, epinephrine series, propofol medium- and long-chain fat emulsion, peritoneal dialysis solutions, and other large-volume injectables and oral formulations, as well as bulk specialty APIs such as caffeine, azithromycin, metronidazole, nifedipine, theophylline, and aminophylline. At the Group’s exhibition booth, the extensive product portfolio and the brand reputation built over more than two decades of deep engagement in the Southeast Asian market drew numerous new and existing customers and industry experts to stop by for discussions and exchanges. On the first day of the show, the Group’s international trade team conducted focused presentations and one-on-one meetings to engage in in-depth outreach with international clients, including those from Vietnam.

“Vietnam is a ‘strategic’ high ground in the Southeast Asian pharmaceutical market, characterized by lengthy and stringent registration and approval processes that place even higher demands on companies’ technical expertise and compliance capabilities,” said a representative from the Group’s Formulation Foreign Trade Center. “Building on this exhibition, we will gain a deeper understanding of local regulatory requirements, accelerate our registration efforts, identify high-quality partners, establish long-term collaborative relationships, and further enhance the accessibility of our injectable formulations, oral dosage forms, and active pharmaceutical ingredients in the Southeast Asian market.”

In recent years, the Group has closely monitored developments in the global pharmaceutical market, leveraging its “going global” strategy and trade fairs as key leverage points to actively expand into diverse overseas markets and accelerate its internationalization. Recently, the Group has made frequent appearances at major global industry exhibitions, using these platforms to showcase its integrated business model—spanning active pharmaceutical ingredients, finished dosage forms, and pharmaceutical packaging—and to deepen engagement and matchmaking with customers, thereby vividly highlighting the new achievements and a fresh corporate image under its integrated development approach. These concerted efforts to expand internationally have effectively fostered deeper collaboration with global clients, secured numerous international business deals, and underscored the Group’s confidence and commitment to actively participating in global competition, injecting new momentum into its international growth.

Keywords:

“Model Workers and Skilled Craftsmen on Campus”: Wei Saili, a Model Worker from Hebei Province and employee of Shijiazhuang Sihua Pharmaceutical Group, Visits Shijiazhuang Institute of Information Engineering to Share Her Story of Struggle

Celebrating the Centennial of the All-China Federation of Trade Unions: Shijiazhuang Sihua Pharmaceutical Employees’ Innovation Achievements Featured in the Municipal Federation’s Themed Exhibition